UNICREDIT BANK/CALL/SANOFI/85/0.1/18.09.24 Share Price

Warrant

DE000HD1E9N2

Market Closed - BOERSE MUENCHEN 20:45:20 03/07/2024 BST
0.8 EUR -1.23% Intraday chart for UNICREDIT BANK/CALL/SANOFI/85/0.1/18.09.24
Current month+2.56%
1 month+2.56%
Date Price Change
03/07/24 0.8 -1.23%
02/07/24 0.81 -11.96%
01/07/24 0.92 +17.95%
28/06/24 0.78 +5.41%
27/06/24 0.74 -9.76%

Real-time BOERSE MUENCHEN

Last update July 03, 2024 at 08:45 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer UniCredit UniCredit
WKN HD1E9N
ISINDE000HD1E9N2
Date issued 27/12/2023
Strike 85
Maturity 18/09/2024 (77 Days)
Parity 10 : 1
Emission price 0.88
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.4
Lowest since issue 0.41
Spread 0.01
Spread %1.22%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
90.23 EUR
Average target price
108.1 EUR
Spread / Average Target
+19.79%
Consensus